Atai: Following the path that Spravato laid and moving beyond it
Investing Experts
Intro
This chapter explores the properties and safety of psychedelic compounds like MDMA in mental health treatments. It highlights Atai Life Sciences' commitment to developing therapies for social anxiety and cognitive impairment, emphasizing the role of unexpected results in innovation.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
